Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

PHASE2CompletedINTERVENTIONAL

Enrollment

359

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

May 31, 2015

Conditions

Glabellar Frown Lines

Interventions

DRUG

Botulinum Toxin Type A

DRUG

Placebo

Trial Locations (8)

Private practice, Birmingham

Private practice, Mobile

Private practice, San Diego

Private practice, Englewood

Private practice, Aventura

Private practice, Nashville

Private practice, San Antonio

Private practice, Salt Lake City